Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis

202028 citationsReviewhybrid Open Access

Authors

Yuchao Wu · First Affiliated Hospital of Xi'an Jiaotong University

Jinfeng Liu · First Affiliated Hospital of Xi'an Jiaotong University

Yali Feng · First Affiliated Hospital of Xi'an Jiaotong University

Shan Fu · First Affiliated Hospital of Xi'an Jiaotong University

Fanpu Ji · Second Affiliated Hospital of Xi'an Jiaotong University

Long Ge · Lanzhou University

Naijuan Yao

Abstract

This network meta-analysis recommended the earlier use of telbivudine or tenofovir, tends to be better to prevent MTCT of HBV in pregnancy with no increased adverse maternal or fetal outcomes.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research HIV/AIDS Research and Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology International

Volume 14, Issue 2, pp. 180-189

DOI: 10.1007/s12072-020-10026-0

Field-Weighted Citation Impact: 2.04